Treatment options for drug-exposed infants.
Kandall
S R
SR
Division of Neonatology, Beth Israel Medical Center, New York, NY 10003, USA.
D005260:Female; D018757:GABA Modulators / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D009270:Naloxone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D009294:Narcotics / Q000009:adverse effects*; D009357:Neonatal Abstinence Syndrome / Q000188:drug therapy*; D009892:Opium / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D011247:Pregnancy
D018757:GABA Modulators; D009292:Narcotic Antagonists; D009294:Narcotics; D010276:Parasympatholytics; D009270:Naloxone; D009892:Opium; C017652:paregoric; D010634:Phenobarbital